GRI Bio, Inc. Files 8-K: Material Agreement & Other Events

Ticker: GRI · Form: 8-K · Filed: Apr 2, 2025 · CIK: 1824293

Gri Bio, INC. 8-K Filing Summary
FieldDetail
CompanyGri Bio, INC. (GRI)
Form Type8-K
Filed DateApr 2, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, 8-k, filing

TL;DR

GRI Bio (GRIB) filed an 8-K on 4/1/25 for a material agreement and other events - details TBD.

AI Summary

GRI Bio, Inc. announced on April 1, 2025, that it entered into a Material Definitive Agreement. The company also reported on other events and filed financial statements and exhibits as part of this 8-K filing. The specific details of the agreement and the nature of the other events are not elaborated upon in the provided text.

Why It Matters

This filing indicates significant corporate activity for GRI Bio, Inc., potentially involving new partnerships, acquisitions, or financial arrangements that could impact its future operations and stock value.

Risk Assessment

Risk Level: medium — The filing indicates a material definitive agreement, which could be positive or negative depending on its terms, and the lack of specific details warrants a medium risk assessment.

Key Players & Entities

FAQ

What is the nature of the Material Definitive Agreement entered into by GRI Bio, Inc. on April 1, 2025?

The provided text states that GRI Bio, Inc. entered into a Material Definitive Agreement on April 1, 2025, but does not specify the details of this agreement.

What other events are being reported in this 8-K filing by GRI Bio, Inc.?

The filing indicates 'Other Events' are being reported, but the specific nature of these events is not detailed in the provided excerpt.

When was GRI Bio, Inc. incorporated and in which state?

GRI Bio, Inc. was incorporated in Delaware.

What is the principal executive office address for GRI Bio, Inc.?

The principal executive office address for GRI Bio, Inc. is 2223 Avenida de la Playa, Suite 208, La Jolla, CA 92037.

What is the Commission File Number for GRI Bio, Inc.?

The Commission File Number for GRI Bio, Inc. is 001-40034.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 2, 2025 regarding GRI Bio, Inc. (GRI).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing